Search for: "Indivior Inc" Results 1 - 20 of 28
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jul 2019, 9:46 pm by Patent Docs
Noonan -- Last month, the Federal Circuit affirmed decisions from four separate trials in the District of Delaware involving seven different defendants regarding validity and infringement of patents directed to an opioid addiction treatment in Indivior Inc. v. [read post]
31 Jul 2020, 2:11 pm by luiza
In addition to its financial aspects, the agreement with Indivior Inc. includes unique provisions that: Require Indivior Inc. to disband its Suboxone sales force and not reinstate it; Require Indivior Inc. [read post]
27 Nov 2018, 9:32 pm by Patent Docs
But in order for a plaintiff to obtain an injunction, she must show a likelihood of prevailing on the merits, and in Indivior Inc. v. [read post]
11 Aug 2020, 9:14 am by Peter Briccetti
Indivior Solutions, the marketing subsidiary of Indivior Inc., admitted that it provided this false information under the direct supervision of its top executives. [read post]
7 Dec 2018, 2:15 am by Steve Brachmann
The Federal Circuit issued a nonprecedential decision in Indivior Inc. v. [read post]
11 Jul 2019, 4:47 pm by Ben Vernia
In December 2014, RB Group spun off Indivior Inc., and the two companies are no longer affiliated. [read post]
19 Feb 2024, 2:15 pm by Dr. Shezad Malik
District Court for the Eastern District of New York, against the drug manufacturers Indivior Inc., Aquestive Therapeutics Inc, Monosol Rx In., and Reckitt Benckiser LLC. [read post]
9 Jan 2020, 11:43 am by luiza
Reckitt — Multiple whistleblowers received awards from the $700 million Reckitt Benckiser Group plc paid to resolve allegations it violated the False Claims Act relating to its marketing and sale of its opioid addiction treatment drug Suboxone (through its then-subsidiary Indivior Inc.). [read post]
9 Jan 2020, 11:43 am by luiza
Reckitt — Multiple whistleblowers received awards from the $700 million Reckitt Benckiser Group plc paid to resolve allegations it violated the False Claims Act relating to its marketing and sale of its opioid addiction treatment drug Suboxone (through its then-subsidiary Indivior Inc.). [read post]
11 Jan 2022, 11:45 am by luiza
This settlement, with all 50 states and DC, is in addition to a $600 million settlement that Indivior reached with the federal government in 2020, placing third on last year’s list, and the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) which topped the 2019 list of healthcare recoveries. [read post]
11 Jan 2022, 11:45 am by luiza
This settlement, with all 50 states and DC, is in addition to a $600 million settlement that Indivior reached with the federal government in 2020, placing third on last year’s list, and the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) which topped the 2019 list of healthcare recoveries. [read post]